Tests a smartphone app for teens with inflammatory bowel disease
Tests a phone app helping teens with inflammatory bowel disease manage medicines.
Plain-language title generated from the registry record
Registry title: Evaluation of the SMART IBD App in Pediatric IBD
Key facts
- Where
- Cincinnati, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 13 and 17 years old?
Source: NCT07195123, who can take part
Where in United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Trial code
- NCT07195123
- Record updated
- 21 November 2025
- Original description
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.Read full original descriptionShow less
Evaluation of the SMART IBD App Digital Therapeutic Tool for Pediatric Inflammatory Bowel Disease
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.
Inclusion: Confirmed diagnosis of IBD (Crohn's Disease, ulcerative colitis, or indeterminate colitis); Prescribed at least one daily or weekly medication for treatment of IBD; <86% adherence to prescribed medication; Access to internet via Wi-Fi or data plan and access to smartphone; English fluency for patient and caregiver.
Exclusion: Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review; Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review.